Table of Content

1 Market Overview of Antisense Oligonucleotide Therapies
1.1 Antisense Oligonucleotide Therapies Market Overview
1.1.1 Antisense Oligonucleotide Therapies Product Scope
1.1.2 Antisense Oligonucleotide Therapies Market Status and Outlook
1.2 Global Antisense Oligonucleotide Therapies Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Antisense Oligonucleotide Therapies Market Size by Region (2024-2034)
1.4 Global Antisense Oligonucleotide Therapies Historic Market Size by Region (2024-2024)
1.5 Global Antisense Oligonucleotide Therapies Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Antisense Oligonucleotide Therapies Market Size (2024-2034)
1.6.1 North America Antisense Oligonucleotide Therapies Market Size (2024-2034)
1.6.2 Europe Antisense Oligonucleotide Therapies Market Size (2024-2034)
1.6.3 Asia-Pacific Antisense Oligonucleotide Therapies Market Size (2024-2034)
1.6.4 Latin America Antisense Oligonucleotide Therapies Market Size (2024-2034)
1.6.5 Middle East & Africa Antisense Oligonucleotide Therapies Market Size (2024-2034)
2 Antisense Oligonucleotide Therapies Market by Type
2.1 Introduction
2.1.1 Without GalNAc-conjugated
2.1.2 With GalNAc-conjugated
2.2 Global Antisense Oligonucleotide Therapies Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Antisense Oligonucleotide Therapies Historic Market Size by Type (2024-2024)
2.2.2 Global Antisense Oligonucleotide Therapies Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Antisense Oligonucleotide Therapies Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Antisense Oligonucleotide Therapies Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Antisense Oligonucleotide Therapies Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Antisense Oligonucleotide Therapies Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Antisense Oligonucleotide Therapies Revenue Breakdown by Type (2024-2034)
3 Antisense Oligonucleotide Therapies Market Overview by Application
3.1 Introduction
3.1.1 Genetic Disease
3.1.2 Cancer
3.1.3 Cardiovascular Diseases
3.1.4 Other
3.2 Global Antisense Oligonucleotide Therapies Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Antisense Oligonucleotide Therapies Historic Market Size by Application (2024-2024)
3.2.2 Global Antisense Oligonucleotide Therapies Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Antisense Oligonucleotide Therapies Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Antisense Oligonucleotide Therapies Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Antisense Oligonucleotide Therapies Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Antisense Oligonucleotide Therapies Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Antisense Oligonucleotide Therapies Revenue Breakdown by Application (2024-2034)
4 Antisense Oligonucleotide Therapies Competition Analysis by Players
4.1 Global Antisense Oligonucleotide Therapies Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Therapies as of 2022)
4.3 Date of Key Players Enter into Antisense Oligonucleotide Therapies Market
4.4 Global Top Players Antisense Oligonucleotide Therapies Headquarters and Area Served
4.5 Key Players Antisense Oligonucleotide Therapies Product Solution and Service
4.6 Competitive Status
4.6.1 Antisense Oligonucleotide Therapies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Ionis Pharmaceuticals
5.1.1 Ionis Pharmaceuticals Profile
5.1.2 Ionis Pharmaceuticals Main Business
5.1.3 Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Products, Services and Solutions
5.1.4 Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Revenue (US$ Million) & (2024-2024)
5.1.5 Ionis Pharmaceuticals Recent Developments
5.2 Sarepta Therapeutics
5.2.1 Sarepta Therapeutics Profile
5.2.2 Sarepta Therapeutics Main Business
5.2.3 Sarepta Therapeutics Antisense Oligonucleotide Therapies Products, Services and Solutions
5.2.4 Sarepta Therapeutics Antisense Oligonucleotide Therapies Revenue (US$ Million) & (2024-2024)
5.2.5 Sarepta Therapeutics Recent Developments
5.3 Nippon Shinyaku
5.3.1 Nippon Shinyaku Profile
5.3.2 Nippon Shinyaku Main Business
5.3.3 Nippon Shinyaku Antisense Oligonucleotide Therapies Products, Services and Solutions
5.3.4 Nippon Shinyaku Antisense Oligonucleotide Therapies Revenue (US$ Million) & (2024-2024)
5.3.5 Recent Developments
6 North America
6.1 North America Antisense Oligonucleotide Therapies Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Antisense Oligonucleotide Therapies Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antisense Oligonucleotide Therapies Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antisense Oligonucleotide Therapies Market Dynamics
11.1 Antisense Oligonucleotide Therapies Industry Trends
11.2 Antisense Oligonucleotide Therapies Market Drivers
11.3 Antisense Oligonucleotide Therapies Market Challenges
11.4 Antisense Oligonucleotide Therapies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Antisense Oligonucleotide Therapies Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Antisense Oligonucleotide Therapies Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Antisense Oligonucleotide Therapies Market Size Share by Region (2024-2024)
Table 4. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Antisense Oligonucleotide Therapies Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Antisense Oligonucleotide Therapies Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Antisense Oligonucleotide Therapies Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Antisense Oligonucleotide Therapies Revenue Market Share by Type (2024-2024)
Table 9. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Antisense Oligonucleotide Therapies Revenue Market Share by Type (2024-2034)
Table 11. North America Antisense Oligonucleotide Therapies Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Antisense Oligonucleotide Therapies Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Antisense Oligonucleotide Therapies Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Antisense Oligonucleotide Therapies Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Antisense Oligonucleotide Therapies Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Antisense Oligonucleotide Therapies Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Antisense Oligonucleotide Therapies Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Antisense Oligonucleotide Therapies Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Antisense Oligonucleotide Therapies Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Antisense Oligonucleotide Therapies Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Antisense Oligonucleotide Therapies Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Antisense Oligonucleotide Therapies Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Antisense Oligonucleotide Therapies Revenue Market Share by Application (2024-2024)
Table 24. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Antisense Oligonucleotide Therapies Revenue Market Share by Application (2024-2034)
Table 26. North America Antisense Oligonucleotide Therapies Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Antisense Oligonucleotide Therapies Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Antisense Oligonucleotide Therapies Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Antisense Oligonucleotide Therapies Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Antisense Oligonucleotide Therapies Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Antisense Oligonucleotide Therapies Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Antisense Oligonucleotide Therapies Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Antisense Oligonucleotide Therapies Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Antisense Oligonucleotide Therapies Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Antisense Oligonucleotide Therapies Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Antisense Oligonucleotide Therapies Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Antisense Oligonucleotide Therapies Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Therapies as of 2022)
Table 39. Date of Key Players Enter into Antisense Oligonucleotide Therapies Market
Table 40. Global Antisense Oligonucleotide Therapies Key Players Headquarters and Area Served
Table 41. Antisense Oligonucleotide Therapies Product Solution and Service
Table 42. Global Antisense Oligonucleotide Therapies Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Ionis Pharmaceuticals Basic Information List
Table 45. Ionis Pharmaceuticals Description and Business Overview
Table 46. Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Products, Services and Solutions
Table 47. Revenue (US$ Million) in Antisense Oligonucleotide Therapies Business of Ionis Pharmaceuticals (2024-2024)
Table 48. Ionis Pharmaceuticals Recent Developments
Table 49. Sarepta Therapeutics Basic Information List
Table 50. Sarepta Therapeutics Description and Business Overview
Table 51. Sarepta Therapeutics Antisense Oligonucleotide Therapies Products, Services and Solutions
Table 52. Revenue (US$ Million) in Antisense Oligonucleotide Therapies Business of Sarepta Therapeutics (2024-2024)
Table 53. Sarepta Therapeutics Recent Developments
Table 54. Nippon Shinyaku Basic Information List
Table 55. Nippon Shinyaku Description and Business Overview
Table 56. Nippon Shinyaku Antisense Oligonucleotide Therapies Products, Services and Solutions
Table 57. Revenue (US$ Million) in Antisense Oligonucleotide Therapies Business of Nippon Shinyaku (2024-2024)
Table 58. Nippon Shinyaku Recent Developments
Table 59. North America Antisense Oligonucleotide Therapies Market Size by Country (2024-2024) & (US$ Million)
Table 60. North America Antisense Oligonucleotide Therapies Market Size by Country (2024-2034) & (US$ Million)
Table 61. Europe Antisense Oligonucleotide Therapies Market Size by Country (2024-2024) & (US$ Million)
Table 62. Europe Antisense Oligonucleotide Therapies Market Size by Country (2024-2034) & (US$ Million)
Table 63. Asia-Pacific Antisense Oligonucleotide Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 64. Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2024-2024) & (US$ Million)
Table 65. Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2024-2034) & (US$ Million)
Table 66. Asia-Pacific Antisense Oligonucleotide Therapies Market Share by Region (2024-2024)
Table 67. Asia-Pacific Antisense Oligonucleotide Therapies Market Share by Region (2024-2034)
Table 68. Latin America Antisense Oligonucleotide Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 69. Latin America Antisense Oligonucleotide Therapies Market Size by Country (2024-2024) & (US$ Million)
Table 70. Latin America Antisense Oligonucleotide Therapies Market Size by Country (2024-2034) & (US$ Million)
Table 71. Middle East & Africa Antisense Oligonucleotide Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 72. Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2024-2024) & (US$ Million)
Table 73. Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2024-2034) & (US$ Million)
Table 74. Antisense Oligonucleotide Therapies Market Trends
Table 75. Antisense Oligonucleotide Therapies Market Drivers
Table 76. Antisense Oligonucleotide Therapies Market Challenges
Table 77. Antisense Oligonucleotide Therapies Market Restraints
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antisense Oligonucleotide Therapies Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Antisense Oligonucleotide Therapies Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Antisense Oligonucleotide Therapies Market Share by Regions: 2022 VS 2034
Figure 4. Global Antisense Oligonucleotide Therapies Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Antisense Oligonucleotide Therapies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Antisense Oligonucleotide Therapies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Antisense Oligonucleotide Therapies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Antisense Oligonucleotide Therapies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Antisense Oligonucleotide Therapies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Without GalNAc-conjugated
Figure 11. Global Without GalNAc-conjugated Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of With GalNAc-conjugated
Figure 13. Global With GalNAc-conjugated Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Antisense Oligonucleotide Therapies Market Size Share by Type: 2022 & 2034
Figure 15. North America Antisense Oligonucleotide Therapies Revenue Market Share by Type (2024-2034)
Figure 16. Europe Antisense Oligonucleotide Therapies Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Antisense Oligonucleotide Therapies Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Antisense Oligonucleotide Therapies Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Antisense Oligonucleotide Therapies Revenue Market Share by Type (2024-2034)
Figure 20. Genetic Disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Cardiovascular Diseases Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global Antisense Oligonucleotide Therapies Market Size Share by Application: 2022 & 2034
Figure 25. North America Antisense Oligonucleotide Therapies Revenue Market Share by Application (2024-2034)
Figure 26. Europe Antisense Oligonucleotide Therapies Revenue Market Share by Application (2024-2034)
Figure 27. Asia-Pacific Antisense Oligonucleotide Therapies Revenue Market Share by Application (2024-2034)
Figure 28. Latin America Antisense Oligonucleotide Therapies Revenue Market Share by Application (2024-2034)
Figure 29. Middle East and Africa Antisense Oligonucleotide Therapies Revenue Market Share by Application (2024-2034)
Figure 30. Antisense Oligonucleotide Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 31. Global Top 5 and Top 10 Players Antisense Oligonucleotide Therapies Market Share in 2022
Figure 32. North America Antisense Oligonucleotide Therapies Market Share by Country (2024-2034)
Figure 33. United States Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 34. Canada Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 35. Germany Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 36. France Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 37. U.K. Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 38. Italy Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 39. Russia Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 40. Nordic Countries Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 41. Asia-Pacific Antisense Oligonucleotide Therapies Market Share by Region (2024-2034)
Figure 42. China Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 43. Japan Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 44. South Korea Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 45. Southeast Asia Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 46. India Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 47. Australia Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 48. Latin America Antisense Oligonucleotide Therapies Market Share by Country (2024-2034)
Figure 49. Mexico Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 50. Brazil Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Antisense Oligonucleotide Therapies Market Share by Country (2024-2034)
Figure 52. Turkey Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 54. UAE Antisense Oligonucleotide Therapies Market Size (2024-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report